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Abstract
Background. The natriuretic peptide (NP) system plays a
central role in the renal adaptations to acute volume ex-
pansion. However, the modulation of the NP system in
chronic renal insufficiency (CRI) remains to be elucidated.
In the present study, we evaluated cardiac haemodynam-
ics, plasma type-B natriuretic peptide (BNP) levels and
the expression of natriuretic peptide receptor A (NPR-A)
and NPR-C in the renal cortex (RC) and medulla (RM) of
Sham and ¾ nephrectomized (¾nx) rats, up to 26 weeks
after surgery.
Methods. Male Wistar–Han rats (190–220 g; n = 49)
were randomly assigned to ¾nx or Sham surgery. Two,
10 and 26 weeks after surgery, non-invasive blood pressure
(BP) and left ventricular (LV) haemodynamics were per-
formed, and urine and blood were collected for metabolic
studies and plasma BNP determination. In addition, tissue
samples from RC and RM were obtained for NPR-A and
NPR-C quantification (RT-PCR and western blotting) as
well as NPR-A immunodetection.
Results. In ¾nx rats, the progressive interstitial fibrosis
and tubular atrophy were accompanied by a time-dependent
increase of BP and impaired natriuretic response to volume
expansion (VE). This was accompanied in ¾nx rats by
an early and time-dependent elevation of BNP circulating
levels that was not associated with cardiac dysfunction or
increased myocardial BNP gene expression. In ¾nx rats,
NPR-A expression in the remnant RM was consistently
reduced at 2, 10 and 26 weeks, and this was accompanied
by an increase in NPR-C expression in the remnant RC
from ¾nx rats.
Conclusions. BP elevation and compromised natriuretic
response to VE in¾nx rats is associated with increased cir-
culating BNP levels in the absence of cardiac dysfunction.
This is accompanied in ¾nx rats by both impaired NPR-A
expression in the RM and upregulation of NPR-C in the
RC suggesting a novel mechanism for NP resistance in
CRI.
Keywords: BNP; chronic renal insufficiency; heart failure;
hypertension; natriuretic peptide receptor
Introduction
The natriuretic peptides (NPs) are a family of signalling
molecules mainly released by the heart to stimulate na-
triuresis, diuresis and vasodilation, contributing to sodium
homeostasis and BP control [1–3]. The natriuretic and di-
uretic actions of NPs are due to both haemodynamic and
direct tubular actions [4–6]. These include dilation of affer-
ent renal arterioles and constriction of efferent arterioles,
leading to increased pressure within the glomerular capillar-
ies and enhanced single nephron glomerular filtration rate
(GFR), shifts in inner medullar blood flow and inhibition of
sodium transport in both proximal and distal nephron seg-
ments [7]. In the latter instance, the NPs have been shown
to inhibit sodium reabsorption in the inner medullary col-
lecting duct (IMCD), a nephron segment that handles <5%
of the filtered sodium load, yet plays a pivotal role in es-
tablishing the final sodium concentration of the urine [8].
Besides the effects on sodium handling and BP control, the
NP system was implicated in limiting the proliferative and
fibrotic response during disease progression [9,10,11] that,
by itself, was suggested to influence directly the NP system
activity [12].
Although the activation of the NP system has been, so
far, evaluated mainly through the NP circulating levels,
evidence is accumulating suggesting a prominent role for
target organ receptor expression in the control of system
activity [13]. The biological effects of NP have been shown
to be mainly mediated through the cell surface family of
guanylyl cyclase (cGMP) linked type-A natriuretic peptide
receptors (NPR-A) [14,18,19] whereas the NP clearance re-
ceptor (NPR-C) is mainly involved in the clearance of NP
through receptor-mediated internalization and degradation
[15–17]. The renal actions of NP can therefore be limited
both by increased NPR-C renal expression and/or by NPR-
A downregulation. Accordingly, several lines of evidence
have suggested that resistance to NP related to changes
in the renal expression of NPR-A may explain in part the
maintenance of volume expansion (VE) in oedema forma-
tion conditions, namely in congestive heart failure [23,24].
In this disease, NP circulating levels are elevated and posi-
tively correlate with VE and poor prognosis [25,26].
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In chronic renal insufficiency (CRI), an increase in NP
circulating levels was observed and this was implicated
in the compensatory increase in GFR and in the decrease
in sodium reabsorption, both under normal and salt-replete
conditions [20]. Although CRI is frequently associated with
disturbances in cardiovascular haemodynamics, the mech-
anisms responsible for the increase of NP circulating levels
in this condition still remain to be elucidated. Moreover, it
is not known whether this is accompanied by changes in the
expression of NPRs in the remnant renal cortex (RC) and
renal medulla (RM) during disease progression. This is a
matter of considerable importance given that (1) substantial
increments of plasma ANP in patients with CRI lead to a
modest natriuretic response when compared to normal con-
trols or to glomerulonephritic patients with well-preserved
renal function [21] and (2) the effects of NP on glomeru-
lar haemodynamics were suggested to occur independently
from those related to the decrease of sodium reabsorption
in renal tubules [22].
On the basis of the previous considerations, the aim of
the present study was to evaluate the activation of the NP
system in CRI and to examine whether this is accompanied
by changes in the expression of renal NPR. For this purpose,
we evaluated cardiac haemodynamics, BP, renal function,
circulating type-B natriuretic peptide (BNP) levels, the na-
triuretic response to VE and the expression of both NPR-A
and NPR-C in the RC and RM, from ¾ nephrectomized
and Sham rats, up to 26 weeks after renal mass ablation.
Materials and methods
Animal experiments were performed according to the Portuguese law on
animal welfare and conform to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals (NIH. Pub. No. 85-23, Revised
1996).
Normotensive male Wistar–Han rats (Harlan, Barcelona, Spain; 190–
220 g) were kept under controlled environmental conditions (12:12 h
light/dark cycle and room temperature 22 ± 2◦C) and were fed ad li-
bitum throughout the study with ordinary rat chow (Panlab, Barcelona,
Spain) containing 1.9 g kg−1 of NaCl. After 1 week, the animals were
randomly submitted to right kidney nephrectomy and surgical ablation
of both poles of the left kidney (¾nx), as previously described [27].
The mean percentage of remnant renal mass in¾nx rats was 27 ± 2%.
Control animals were rats submitted to sham surgery under similar condi-
tions (Sham). Metabolic, haemodynamic, morphometric, histological and
molecular studies were performed 2 (n = 12), 10 (n = 14) and 26 weeks
(n = 17) after surgery.
Metabolic studies
Two, 10 and 26 weeks after surgery, the rats were placed in metabolic cages
(Tecniplast, Buguggiate-VA, Italy). Twenty-four-hour urine was collected
to calculate creatinine clearance (CCreat, ml min
−1 kg body wt−1) and
fractional excretion of sodium (FENa+ , %).
Haemodynamic evaluation
BP (systolic and diastolic) and heart rate were measured weekly in con-
scious restrained animals (7.00–10.00 AM), using a photoelectric tail-cuff
pulse detector (LE 5000, Letica, Barcelona, Spain). Four determinations
were made each time, and the means were used for further analysis.
At 2, 10 and 26 weeks, the animals were anaesthetized with pentobar-
bital (6 mg/100 g, i.p.), placed over a heating pad and tracheostomized
for mechanical ventilation with oxygen (Harvard Small Animal Ventila-
tor, Model 683, Massachusetts, USA), with rate and volume adjustment
for body weight. Anaesthesia was maintained with additional bolus of
pentobarbital (2 mg/100 g) as needed. The heart was exposed through a
median sternotomy and the pericardium widely opened. Left ventricular
(LV) pressures were measured with a 2F high-fidelity micromanometer
(SPR-324, Millar Instruments, TX, USA) inserted into the LV. After com-
plete instrumentation, the animal preparation was allowed to stabilize for a
few minutes. Haemodynamic recordings were made with respiration sus-
pended at end expiration. The parameters were converted online to digital
data with a sampling frequency of 1000 Hz. LV pressures were mea-
sured at end-diastole and peak-systole. The peak rates of LV pressure rise
(dP/dtmax) and pressure fall (dP/dtmin) were also measured. The relax-
ation rate was estimated with the time constant τ by fitting isovolumetric
pressure fall to a monoexponential function.
At the end of the experimental protocol, the animals were euthanized
and blood was collected in lithium/heparin tubes for sodium, creatinine
and BNP quantification. Also, samples from the LV, RC and RM were snap
frozen in liquid nitrogen and stored (−70◦C) for mRNA quantification. In
addition, renal tissue samples were paraffin-embedded and formalin-fixed
for histology and immunohistochemistry.
Volume expansion
In another set of experiments, 2, 10 and 26 weeks after the surgery, the an-
imals were anaesthetized with pentobarbital sodium (60 mg kg body wt−1
followed by 20 mg kg−1 h−1; i.p.), placed on a thermostatically controlled
heating table to maintain rectal temperature at 37◦C and tracheostomized.
The left jugular vein was catheterized by a PE50 tube (Becton Dickson,
Lisboa, Portugal) for VE. After an abdominal incision, the urinary bladder
was catheterized through a suprapubic incision for urine sampling. Af-
ter the completion of surgical procedures, the infusion of isotonic saline
(0.9%) started at a rate of 5 ml kg−1 h−1 for 120 min; during this period a
urine sample was collected (t= 0–120 min, Basal). After this stabilization
period, the VE was started by infusion of isotonic saline (0.9%) at a rate of
100 ml kg−1 h−1 during 30 min (5% body weight); during this phase, one
urine sample was collected (t= 150 min, VE). Thereafter, the infusion was
again reduced to 5 ml kg−1 h−1 for 90 min; during this recovery period,
three urine samples were collected (t = 160 min, VER-1; t = 170 min,
VER-2 and t = 240 min, VER-3).
Plasma BNP quantification
BNP levels were quantified by a competitive radioimmunoassay after
extraction of peptides from plasma, according to the manufacturer’s in-
structions (RK-011–14; Phoenix Pharmaceuticals; Belmont, CA, USA).
Briefly, in each reaction, rabbit anti-peptide antibody was incubated (16–
24 h at 4◦C) with sample or standard and mixed with a fixed amount
of 125I-peptide. After a second incubation period (16–24 h at 4◦C), goat
anti-rabbit serum and normal rabbit serum are added and incubated for
90 min. The reaction tubes were subsequently centrifuged and the pellet
counted in a Gamma counter. By measuring the amount of 125I-peptide
bound as a function of the standard peptide concentration, a ‘standard
curve’ was constructed from which the BNP concentration of each sample
was calculated. Results are expressed as pg/tube.
Renal histology and immunohistochemistry
Kidney sections, 4 µm thick, of paraffin-embedded formalin-fixed spec-
imens were deparaffinized in xylene and rehydrated through graded
ethanols.
Renal fibrosis. Collagen detection with Masson’s trichrome staining
(Goldner with light green; Bio-Optica, 011802, Milan, Italy) was per-
formed to evaluate interstitial renal fibrosis. Sections were stained sequen-
tially with Weigert’s iron haematoxylin (10 min), picric acid alcoholic sta-
ble solution (4 min), Ponceau acid fuchsin (4 min), phosphomolybdic acid
(10 min) and light green (5 min). The number of green-stained collagen
intersecting points on a grid was used for interstitial fibrosis quantifi-
cation in 12 randomly selected fields (×200 magnification). Results are
expressed as the mean number of grid points falling on collagen.
Tubular atrophy. Tubular basement membrane (TBM) thickening was
used to detect tubular atrophy, as previously described [28]. TBM was iden-
tified by periodic acid Schiff (PAS) staining (Hotchkiss-MC Manus; Bio-
Optica, 04-130802, Milan, Italy). Sections were stained sequentially with
periodic acid (10 min), Schiff reagent (20 min), potassium metabissulphite
(2 min), fixative solution (2 min) and Mayer’s Hemalum (3 min). In each
experimental group, TBM thickening was measured in 100 cross-sectioned
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tubules (50 tubules in cortex, 50 tubules in medulla). Results were ex-
pressed as the percentage of TBM thickened cross-sectioned tubules.
Immunolocalization of NPR-A. Kidney paraffin sections, 4 µm thick,
were placed in 0.1% poly-L-lysine-covered microscopy slides (Menzel
GmbH, Braunschweig, Germany) for immunohistochemical detection
of NPR-A using the appropriate polyclonal primary antibody diluted
to 1/250 (Abcam, Cambridge, UK). Immunoperoxidase staining was
performed by an anti-rabbit secondary biotinylated antibody diluted to
1/300 (Vector Laboratories) combined with a streptavidin–peroxidase
complex diluted to 1/50 (Vector Laboratories). After counterstaining
with haematoxylin, the slides were observed in a light microscope (Leica
Application Suite Software, Leica Microsystems, Wetzlar, Germany).
mRNA relative quantification by real-time PCR (RT-PCR)
Total mRNA was extracted through the guanidium-thiocyanate selective
silica-gel membrane-binding method (Qiagen 74124, Hilden, Germany)
according to the manufacturer’s instructions. The concentration and purity
were assayed by spectrophotometry (Eppendorf 6131000.012).
RT-PCR. Two-step RT-PCR was used to perform relative quantification
of mRNA. For each studied mRNA molecule, standard curves were gen-
erated from the correlation between the amount of starting total mRNA
and PCR threshold cycle (second derivative maximum method) of graded
dilutions from a randomly selected tissue sample (r > 0.97). For relative
quantification of specific mRNA levels, 50 ng of total mRNA from each
sample underwent two-step RT-PCR. A melt curve analysis of each RT-
PCR and 2% agarose gels (0.5 µg/ml ethidium bromide) were performed
to exclude primer–dimer formation and assess the purity of the amplifi-
cation product. The GAPDH mRNA level was used as an internal control
gene. The results of mRNA quantification are expressed in an arbitrary
unit (AU) set as the average value of the sham group (sham = 1 AU), after
normalization for GAPDH.
RT (20 µl; 10 min at 22◦C, 50 min at 50◦C and 10 min at 95◦C)
was performed in a standard thermocycler (Whatman Biometra 050-901,
Go¨ttingen, Germany): 40 U/reaction of reverse transcriptase (Invitrogen
18064-014, California, USA), 20 U/reaction of RNase inhibitor (Promega
N2515, Wisconsin, USA), 30 ng/ml random primers (Invitrogen
48190-011, California, USA), 0.5 mM nucleotide mix (MBI Fermentas
R0192, Ontario, Canada), 1.9 mM MgCl2 and 10 mM DTT. Ten percent
of the cDNA yield was used as a template for RT-PCR (LightCycler,
Roche, Indianapolis, USA) using SYBR green (Qiagen 204143, Hilden,
Germany) according to the manufacturer’s instructions.
Specific PCR primer pairs for the studied genes were NPR-A—fw
5′-ACA CAT GCC CAG TCC CAC CCT TAC-3′ and rev 5′-AAC CGG
CAG CTT CTC TTC TCC TCA-3′; NPR-C—fw 5′-GGA CCG CGA AGC
CTG AGT TTG AGA-3′ and rev 5′-ATG GAC ACC TGC CCG GCG ATA
CCT-3′; BNP—fw 5′-CAG AGC TGG GGA AAG AAG AG-3′ and rev
5′-GGA CCA AGG CCC TAC AAA AGA-3′ and GAPDH—fw 5′-CCG
CCT GCT TCA CCA CCT TCT-3′ and rev 5′-TGG CCT TCC GTG TTC
CTA CCC-3′.
Semi-quantification of NPR-A and NPR-C protein levels by the
western-blotting technique
Samples from RC and RM were mixed with a sample buffer (0.35 M
tris-HCl, 4% SDS, 30% glycerol, 9.3% DTT, ph 6.8, 0.01% bromphenol
blue), boiled at 95◦C for 5 min and separated by SDS-PAGE in 7.5%
poly-acrylamide gel (80 µl of sample/well). For immunoblotting, total
proteins were transferred to a nitrocellulose membrane (Bio-Rad Labo-
ratories, California, USA) and incubated overnight at 4◦C with constant
shaking with the specific anti-NPR-A (dilution 1/250) and anti-NPR-C
(dilution 1/100) polyclonal primary antibodies (Abcam, Cambridge, UK).
Protein loading was normalized using the mouse polyclonal anti-GAPDH
diluted to 1/15 000 (Santa Cruz Biotechnology, USA). The immunoblots
were subsequently washed and incubated at room temperature and pro-
tected from light with the fluorescently labelled donkey anti-rabbit to IgG
and goat anti-mouse to IgG, both diluted to 1/20 000 (IRDye800, and
IRDye700, Rockland, PA, USA). The membrane was finally washed and
the signal detected by scanning using an Odyssey Infrared Imaging Sys-
tem at 800 nm and 700 nm (LI-COR Biosciences, Lincoln, NE, USA).
The intensity values of the detected bands were evaluated using Sham as
a reference group (Sham = 100%).
Statistical analysis
Group data are presented as means ± SE. Differences between experimen-
tal groups were analysed by two-way ANOVA followed by the Student–
Newman–Keuls test for multiple comparisons. Statistical significance was
set at P < 0.05.
Results
Morphometry and renal function
Renal mass ablation had no effects on body growth, as
¾nx rats attained the same weight at 26 weeks as Sham
rats (Table 1). This was accompanied in ¾nx rats by a
progressive increase in the remnant renal mass throughout
the study; 26 weeks after the surgery the remnant kidney
from ¾nx rats weighted 257 ± 15% more than on the day
of the surgery (Table 1). Ablation of renal mass in ¾nx
rats resulted in a significant and progressive increase in the
heart weight from 2 to 26 weeks after the surgery (Table 1).
This contrasted with that observed in Sham rats in which
the heart weight increased from 2 to 10 weeks after surgery
but not from 10 to 26 weeks after surgery (Table 1). As a
result, 26 weeks after surgery, the heart weight of the ¾nx
group was significantly higher than that of the Sham group
(Table 1).
The ¾nx rats presented significant increases in plasma
creatinine values throughout the study, this being accom-
panied by 50–60% reductions in the creatinine clearance
values in comparison with Sham rats (Table 1). No progres-
sive changes were observed between Sham and¾nx rats in
daily urinary excretion of sodium throughout the study. This
resulted in that the fractional excretion of sodium in ¾nx
rats was consistently increased by ∼2.5-fold throughout the
study.
Ablation of renal mass in ¾nx rats resulted in a time-
dependent increase of both renal fibrosis and tubular atro-
phy from 2 to 26 weeks after surgery (Figure 2). This con-
trasted with the changes observed in Sham rats in which
renal fibrosis and tubular atrophy only slightly increased
from 10 to 26 weeks after surgery (Figure 2). Therefore,
both renal fibrosis and tubular atrophy were increased much
more in¾nx rats than in Sham animals at 10 and 26 weeks
after surgery (Figure 2).
Natriuretic response to VE
Two weeks after the surgery the natriuretic response to VE
was similar between ¾nx and Sham rats. In contrast, 10
weeks after the surgery the natriuretic response to VE was
decreased in ¾nx rats when compared with Sham rats at
VER-1 (t= 160 min). Moreover, 26 weeks after the surgery
the natriuretic response to VE was decreased in ¾nx rats,
both at VER-1 (t = 160 min) and VER-2 (t = 170 min)
(Figure 1).
BP and cardiac haemodynamics
Ablation of renal mass in ¾nx rats resulted in a signifi-
cant and time-dependent increase in both systolic and dias-
tolic BPs from 2 to 26 weeks after surgery. In addition, at
26 weeks after surgery both systolic and diastolic BPs were
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Table 1. Morphometry, renal function, blood pressure and heart rate in sham-operated (Sham) and ¾ nephrectomized (¾nx) rats 2, 10 and
26 weeks after surgery
2 weeks 10 weeks 26 weeks
Sham ¾nx Sham ¾nx Sham ¾nx
Body wt (g) 255 ± 5 247 ± 5 417 ± 6‡ 409 ± 15‡ 486 ± 14‡,δ 462 ± 7‡,δ
Heart wt (g) 6.74 ± 0.02 0.77 ± 0.02 1.05 ± 0.03‡ 1.11 ± 0.04‡ 1.08 ± 0.06‡ 1.32 ± 0.04∗,‡,δ
Renal mass increase (%) 99 ± 10† 191 ± 17‡ 257 ± 15‡,δ
PCreat (mg dl
−1) 0.34 ± 0.02 0.76 ± 0.04∗ 0.31 ± 0.03 0.69 ± 0.07∗ 0.55 ± 0.02‡,δ 1.27 ± 0.17∗,‡,δ
CCreat (ml min
−1 kg body wt−1) 8.8 ± 1.0 3.5 ± 0.3∗ 10.8 ± 1.0 4.6 ± 0.7∗ 4.1 ± 0.3‡,δ 2.0 ± 0.2∗,‡,δ
FENa+ (%) 0.36 ± 0.04 0.89 ± 0.06∗ 0.23 ± 0.05 0.67 ± 0.10∗ 0.33 ± 0.04 0.8 ± 0.10∗
Systolic BP (mmHg) 123 ± 3 139 ± 4∗ 128 ± 3 187 ± 6∗,‡ 136 ± 2‡,δ 209 ± 4∗‡,δ
Diastolic BP (mmHg) 80 ± 3 106 ± 4∗ 92 ± 2‡ 142 ± 5∗,‡ 101 ± 3‡,δ 156 ± 4∗,‡
Heart rate (beats min−1) 415 ± 12 473 ± 32 340 ± 10 395 ± 11 322 ± 7 387 ± 9
Data are means ± SE.
Body wt, body weight; Heart wt, heart weight; PCreat, plasma creatinine; CCreat, creatinine clearance; FENa+ , Na
+ fractional excretion; BP, blood
pressure.
∗P < 0.05 versus Sham; ‡P < 0.05 versus 2 weeks.
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Fig. 1. Urinary sodium excretion of¾ nephrectomized rats (¾nx) before (t = 0–120 min, Basal), during (t = 150 min, VE) and after (t = 160 min,
VER-1; t = 170 min, VER-2 and t = 240 min, VER-3) 5% volume expansion (VE) with isotonic saline at 2, 10 and 26 weeks after surgery. Two weeks
after the surgery, no differences were observed in the natriuretic response to VE between¾nx and Sham rats. However, the natriuretic response to VE
was markedly decreased in¾nx when compared with Sham rats at VER-1 (t = 160 min) 10 weeks after the surgery and both at VER-1 (t = 160 min)
and VER-2 (t = 170 min) 26 weeks after the surgery. Values represent the means of 5–8 experiments per group and are expressed in mol g creatinine−1.
∗P < 0.05 versus Sham; †P < 0.05 versus 2 weeks; ‡P < 0.05 versus 10 weeks.
increased in Sham rats in comparison with those observed
at 2 and 10 weeks. Moreover, both systolic and diastolic
BPs were significantly higher in¾nx rats than in Sham rats
throughout the study (Table 1).
The haemodynamic features of the two experimental
groups at 2, 10 and 26 weeks after surgery are summarized
in Table 2. Regarding the systolic parameters, no signifi-
cant differences were detected in the maximum developed
pressures (LVPmax) as well as in the index of contractility
(dP/dtmax) between the two groups throughout the study.
Also, the LV filling pressures estimated by LVEDP and the
relaxation time constant τ were similar between Sham and
¾nx rats at 2, 10 and 26 weeks after surgery.
BNP circulating levels and BNP myocardial expression
Despite the absence of cardiac dysfunction, a signifi-
cant elevation of BNP circulating levels was observed at
some point during the study in both experimental groups
(Table 3). Ablation of renal mass in ¾nx rats resulted in a
significant and sustained increase in BNP circulating levels
at 2 and 10 weeks after surgery with further increase at 26
weeks after renal mass ablation, whereas in Sham rats a
significant increase in BNP circulating levels was observed
from 10 to 26 weeks after surgery (Table 3). As a conse-
quence, BNP circulating levels at 26 weeks were similar
between the two groups. No significant differences were
observed in BNP mRNA expression of LV cells between
the two groups.
Expression of NPR-A and -C in the RC and RM
In control rats, basal NPR-A and NPR-C expression dif-
fered between the RC and RM: NPR-A mRNA levels were
higher in the RM (cortex: 1.0 ± 0.40 AU; medulla: 14.0 ±
3.10 AU), whereas NPR-C mRNA levels were higher in
the RC (cortex: 1.0 ± 0.17 AU; medulla: 0.37 ± 0.02 AU)
(Figure 3).
A time-dependent increase in NPR-A mRNA levels in the
RM was observed in both experimental groups throughout
the study (Figure 3). However, the mRNA expression levels
of NPR-A in the RM from¾nx rats were significantly lower
than those observed in Sham rats, at 2, 10 and 26 weeks
after surgery. In agreement with these findings, the protein
levels of NPR-A in the remnant RM of ¾nx rats were
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Table 2. Left ventricular haemodynamics in sham-operated (Sham) and¾ nephrectomized (¾nx) rats 2, 10 and 26 weeks after surgery.
2 weeks 10 weeks 26 weeks
Sham ¾nx Sham ¾nx Sham ¾nx
LVPmax (mmHg) 77.4 ± 8.0 71.5 ± 6.4 85.2 ± 15.6 102.3 ± 7.4 87.8 ± 6.8 76.3 ± 9.2
dP/dtmax (mmHg/s) 4212 ± 642 4114 ± 335 4716 ± 1062 5823 ± 405 4608 ± 458 3635 ± 568
dP/dtmin (mmHg/s) −2259 ± 309 −2205 ± 172 −2669 ± 673 −3282 ± 391 −2582 ± 297 −2117 ± 340
LVEDP (mmHg) 2.9 ± 0.9 3.2 ± 1.3 2.3 ± 0.5 3.9 ± 0.4 3.7 ± 0.7 3.1 ± 0.5
τ (ms) 20 ± 2 17 ± 2 21 ± 2 21 ± 2 21 ± 1 22 ± 1
Data are means ± SE.
LVPmax, LV peak systolic pressure; dP/dtmax and dP/dtmin, peak rates of ventricular pressure rise and fall, respectively; LVEDP, LV end-diastolic
pressure; τ, time constant of isovolumetric relaxation.
No significant differences were detected in the studied haemodynamic parameters between groups at 2, 10 and 26 weeks.
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Fig. 2. Interstitial fibrosis and tubular atrophy in sham-operated (Sham)
and¾ nephrectomized (¾nx) rats 2, 10 and 26 weeks after surgery. Renal
mass ablation was associated with progressive renal fibrosis at 10 and 26
weeks, as detected by increased collagen staining (Masson’s trichrome) and
tubular basement membrane thickening (periodic acid Schiff). Increased
tubular basement membrane thickness was also observed in the Sham
group at 26 weeks. ∗P < 0.05 versus Sham; ‡P < 0.05 versus 2 weeks;
δP < 0.05 versus 10 weeks.
Table 3. Plasma levels of BNP in sham-operated (Sham) and ¾
nephrectomized (¾nx) rats 2, 10 and 26 weeks after surgery
2 weeks 10 weeks 26 weeks
Sham 1.35 ± 0.39 2.85 ± 0.67 4.43 ± 0.32∗‡
¾nx 2.95 ± 0.81∗ 3.86 ± 0.43∗ 4.58 ± 0.20∗‡
Data are mean ± SE in pg/reaction.
∗P < 0.05 versus Sham 2 weeks; ‡P < 0.05 versus 2 weeks.
significantly lower than those observed in Sham animals at
26 weeks (Figure 4).
The expression levels of NPR-A in the RC from ¾nx
rats increased throughout the study, whereas in Sham an-
imals the expression levels of NPR-A in the RC only
slightly increased at 26 weeks after surgery (Figure 3).
NPR-A mRNA levels in the RC from¾nx rats were, there-
fore, higher than those observed in Sham, both at 10 and
26 weeks after surgery. In contrast, at 26 weeks, the pro-
tein levels of NPR-A in the remnant RC of ¾nx rats were
significantly lower than those observed in Sham animals
(Figure 4).
The expression levels of NPR-C in the RC from Sham
rats did not change throughout the study. In contrast, NPR-
C mRNA levels in the remnant RC from ¾nx rats were
higher at 10 and 26 weeks after surgery than at 2 weeks.
This was accompanied at 10 and 26 weeks after surgery by
higher NPR-C mRNA levels in the RC of ¾nx rats than in
Sham rats (Figure 3). Accordingly, at 26 weeks the NPR-C
protein levels were significantly higher in the RC of ¾nx
rats than in Sham animals (Figure 5).
The expression levels of NPR-C in the RM did not change
overtime in either ¾nx or Sham animals. NPR-C protein
levels in the RM were only faintly detected by western
blotting in both experimental groups.
NPR-A was detected by immunohistochemical staining
in the RC and RM from both Sham and¾nx rats. In agree-
ment with the findings of decreased NPR-A protein levels
in the RC and RM of¾nx rats by western blotting, NPR-A
immunodetection at 26 weeks was lower in ¾nx rats than
in Sham, in both RC and RM (Figure 6).
Discussion
In the present study, BP elevation and compromised na-
triuretic response to VE in ¾nx rats was associated with a
precocious and time-dependent increase in circulating BNP
levels, in the absence of cardiac dysfunction. This was ac-
companied by an early, selective and sustained impaired ex-
pression of NPR-A in the RM along with an upregulation
of NPR-C in the RC. Taken together, our results demon-
strate a distinct modulation of NPRs in the remnant kidney
that could represent a novel mechanism for NP resistance
in CRI.
A distinct expression of NPR-A and NPR-C in the RC
and RM was observed in Sham rats. Two weeks after
the surgery, NPR-A mRNA levels in the RM were 14-
fold higher than in the RC whereas the NPR-C expres-
sion in the RC was 3-fold higher than in the RM. Our
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Fig. 3. mRNA quantification by RT-PCR of RPN-A and RPN-C in the renal cortex (RC) and medulla (RM) of sham-operated (Sham) and ¾
nephrectomized (¾nx) rats 2, 10 and 26 weeks after surgery. Basal NPR-A and NPR-C expression differed in the RC and RM, with higher mRNA
levels of NPR-A detected in the RM and higher NPR-C basal expression in the RC of Sham animals. Renal mass ablation was associated with reduced
expression of NPR-A in the medulla at 2, 10 and 26 weeks after surgery, with no significant differences in NPR-C expression. Differently, both NPR-A
and NPR-C were upregulated in the RC in the¾nx group. At 26 weeks, an upregulation of NPR-A expression was also evident in the RM of the Sham
animals. ∗P < 0.05 versus Sham; ‡P < 0.05 versus 2 weeks; δP < 0.05 versus 10 weeks.
Fig. 4. NPR-A protein levels evaluated by western blotting in renal medulla (RM) and renal cortex (RC) of sham-operated (Sham) and¾ nephrectomized
(¾nx) rats 26 weeks after surgery. At 26 weeks, significantly lower protein levels of NPR-A were observed in the RM and RC of¾nx when compared
to Sham animals. Results shown as the percentage of control (Sham = 100%). ∗P < 0.05 versus Sham. Bottom: representative immunoblots of
NPR-A and GAPDH in the RM and RC of Sham and¾nx rats 26 weeks after surgery (118 and 35 kDa bands, respectively).
findings are in agreement with those from previous stud-
ies performed in normal kidneys showing that the expres-
sion of NPR-A predominates in the medullary collecting
duct, whereas the expression of NPR-C predominates in
the cortical structures [29]. The increased expression of
NPR-A in the RM fits well with the notion that the na-
triuresis induced by NP is mainly related to the tubular
effects of these peptides [30]. On the other hand, the in-
creased expression of NPR-C in the RC suggest that this
clearance receptor may play an important role in the mod-
ulation of the concentrations of NP available to interact
with NPR-A in both cortical and medullar structures. This
would be also in agreement with the view that the con-
centration of NP downstream of the glomeruli may be sig-
nificantly influenced by the expression of NPR-C in the
RC [31].
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Fig. 5. NPR-C protein levels evaluated by western blotting in renal cortex
(RC) of sham-operated (Sham) and ¾ nephrectomized (¾nx) rats 26
weeks after surgery. At 26 weeks, significantly higher protein levels of
NPR-C were observed in the RC of¾nx when compared to Sham animals.
Results shown as the percentage of control (Sham = 100%). ∗P < 0.05
versus Sham. Bottom: representative immunoblots of NPR-C and GAPDH
in RC of Sham and¾nx rats 26 weeks after surgery (63 and 35 kDa bands,
respectively).
Twenty-six weeks after the surgery, Sham rats presented
an increase in BP going along with a decrease in GFR. This
was accompanied by an increase in BNP circulating levels,
in the absence of cardiac dysfunction. An elevation of BNP
circulating levels was previously described in normal aged
subjects in the absence of cardiac dysfunction and this was
attributed to a decrease in the renal clearance of NP [32,33].
Thus, our findings agree well with the suggestion that both
age and renal function should be taken in consideration
when BNP circulating levels are evaluated [34,35]. How-
ever, we did not compare BNP and NT-proBNP circulating
levels, which could have contributed to clarify the mech-
anisms involved in decreased BNP degradation/excretion
observed in our study and to evaluate the role of impaired
neutral endopeptidase activity as a possible mechanism for
increased BNP circulating levels in decreased GFR.
A time-dependent increase in NPR-A mRNA levels was
observed in the RM of Sham rats. This was accompanied
by a slight increase in NPR-A mRNA levels in the RC
at 26 weeks in the absence of changes in both cortical
and medullar NPR-C expression overtime. Taken together
our findings in Sham rats may suggest an important role
of the NP system in the control of sodium balance that
accompanies the increase of BP associated with ageing. In-
terestingly, previous human studies reported an increase in
the urinary cGMP levels in essential hypertensives suggest-
ing that they may be a marker of higher than normal tubular
actions of NP [36].
Renal mass ablation in ¾nx rats was accompanied by
an early and sustained increase in BNP circulating levels
that was not related to an augmented myocardial produc-
tion of BNP, as evidenced by the normal expression of BNP
mRNA levels in ventricular cells as well as by the absence of
signs of cardiac dysfunction. These results are in agreement
with recent observations suggesting that an impaired renal
clearance of NP could be an important determinant of BNP
Fig. 6. Immunolocalization of NPR-A in renal medulla of sham-operated (Sham) and¾ nephrectomized (¾nx) rats 26 weeks after surgery. NPR-A
was detected by immunohistochemical staining in the tubular structures of the renal cortex (RC) and medulla (RM) from both Sham and¾nx rats. At
26 weeks after surgery, NPR-A immunodetection in both RC and RM was lower in¾nx rats than in Sham animals. Amplification used: 100× in the
RC and 200× in the RM.
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circulating levels in moderate-to-severe CRI [37,38]. In
fact, ¾nx animals developed a time-dependent dramatic
increase in BP and also hypervolaemia. Both hypertension
and hypervolaemia result in increased plasma BNP levels
independent of cardiac dysfunction. In addition, any moder-
ate or particularly severe reduction in glomerular filtration
rate results in an increase in BNP even in the absence of
cardiac dysfunction. However, this was a short-term study,
and cardiac dysfunction may develop in the long term also
in these animals as a result of severe hypertension and/or
hypervolaemia.
Despite the increase in BNP circulating levels, the ¾nx
rats presented a time-dependent increase in BP and re-
sponded to VE with a blunted natriuretic response. Taken
together, these findings agree well with the suggestion that
the failing kidney may be hyporesponsive to NP actions
[20,21]. In our study, renal mass ablation had a profound
impact on NPR expression, in both the RC and RM. An
early and sustained decrease in NPR-A expression in the
RM of ¾nx rats was observed, and this was accompanied
by a time-dependent increase in the expression of RPN-C in
the RC. This later finding does not seem to be dependent on
increased circulating BNP levels, given that at 26 weeks cir-
culating BNP levels were similar between Sham and ¾nx
groups and NPR-C was not upregulated in Sham. Since
NPR-C in the kidney was suggested to decrease the lo-
cal concentration of delivered NP [31] in a dose-dependent
manner, one can speculate that the increase in NPR-C ex-
pression in the RC of ¾nx rats along with the decrease in
NPR-A expression in the remnant RM of¾nx rats may both
contribute to an attenuated renal response to NP in CRI. De-
spite the increase in NPR-A mRNA levels observed in the
RC of ¾nx rats at 26 weeks after the surgery, the protein
levels of NPR-A were decreased in the RC of ¾nx rats at
this time period. Although one cannot go ahead with an
explanation for this apparent discrepancy, the findings of
reduced NPR-A protein levels in the RC of¾nx rats further
reinforce the view of markedly attenuated effects of NP in
the remnant kidney. Interestingly, patients with pulmonary
hypertension were found to present increased circulating
BNP levels and renal hyporesponsiveness to NP that was
suggested to be located upstream to cGMP generation in
renal tubules [39].
In¾nx rats, the disturbances in sodium balance observed
were accompanied by a progressive increase in tubular at-
rophy and interstitial fibrosis. Previous studies in animal
models of immune glomerular injury have reported several
antifibrotic and antiproliferative effects of the NP system
[10]. Thus, one can hypothesize that the renal hyporespon-
siveness to NP actions suggested by the local changes in
NPR-A and NPR-C expression in the RC and RM of ¾nx
rats may operate as a contributing factor to the tubular and
interstitial changes observed in these animals as well as to
progressive loss of renal function. However, the exact role
of the NP system in the regulation of the fibrotic response
in CRI progression remains to be elucidated.
In conclusion, BP elevation and compromised natriuretic
response to VE in ¾nx rats was associated with increased
circulating BNP levels in the absence of cardiac dysfunc-
tion. This was accompanied in ¾nx rats by both impaired
NPR-A expression in the RM and upregulation of NPR-C
in the RC suggesting a novel mechanism for NP resistance
in CRI.
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Abstract
Background. Activation of protein kinase C (PKC) has
been implicated in the pathogenesis of diabetic nephropathy
where therapy targeting the β isoform of this enzyme is in
advanced clinical development. However, PKC-β is also
increased in various forms of human glomerulonephritis
with several potentially nephrotoxic factors, other than high
glucose, resulting in PKC-β activation. Accordingly, we
sought to examine the effects of PKC-β inhibition in a non-
diabetic model of progressive kidney disease.
Methods.Subtotally nephrectomized (STNx) rats were ran-
domly assigned to receive either the selective PKC-β in-
hibitor, ruboxistaurin or vehicle. In addition to functional
and structural parameters, gene expression of the podocyte
slit-pore diaphragm protein, nephrin, was also assessed.
Results. STNx animals developed hypertension, protein-
uria and reduced glomerular filtration rate (GFR) in associ-
ation with marked glomerulosclerosis and tubulointerstitial
fibrosis. Glomerular nephrin expression was also reduced.
Without affecting blood pressure, ruboxistaurin treatment
attenuated the impairment in GFR and reduced the extent
of both glomerulosclerosis and tubulointerstitial fibrosis in
STNx rats. In contrast, neither proteinuria nor the reduction
in nephrin expression was improved by ruboxistaurin.
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